Webinar Date/Time: Session 1: Tuesday, October 15th, 2024 at 11am EDT | 3pm BST | 4pm CEST Session 2: Tuesday, October 15th, 2024 at 11am PDT | 1pm CST | 2pm EDT Session 3: Wednesday, October 16th, 2024 at 10:30am IST | 1pm CST | 2pm JST
Various types of nucleic acids, such as antisense oligonucleotides, small interfering RNAs (siRNAs), and aptamers, are being explored for their potential in therapeutic applications. The production of synthetic oligonucleotides typically results in numerous impurities due to the inherent inefficiencies in each step of the chemical synthesis process. These impurities include deletion sequences (missing one or more nucleotides) and by-products that often form during the final deprotection or cleavage stages.
Register Free: https://www.chromatographyonline.com/ca_w/unlock
Event Overview:
Various types of nucleic acids, such as antisense oligonucleotides, small interfering RNAs (siRNAs), and aptamers, are being explored for their potential in therapeutic applications. The production of synthetic oligonucleotides typically results in numerous impurities due to the inherent inefficiencies in each step of the chemical synthesis process. These impurities include deletion sequences (missing one or more nucleotides) and by-products that often form during the final deprotection or cleavage stages.
Ion pair reversed-phase (IP-RP) chromatography is the dominant technique for the analysis and purification of oligonucleotides.
Attend this webinar to learn how to achieve superior resolution and separation of oligo therapeutics from the many structurally similar impurities found in a crude sample. Understand how to scale up your optimized analytical method to semi-prep and preparative purification with the same column chemistry.
Key Learning Objectives:
Who Should Attend:
Speaker:
Andrea Angelo P. Tripodi
Application Chemist for BioHPLC columns and consumables
Agilent Technologies UK
Andrea Angelo Tripodi joined Agilent Technologies as an Applications Chemist in September 2019 after completing his Marie Curie PhD in Organic Chemistry, specifically focused on the development of peptide drug-conjugates for cancer therapy at ELTE University in Budapest (Hungary) within the MAGICBULLET ITN Network. He now develops LC-UV and LC/MS applications for biomolecule analysis and purification using a wide variety of approaches, including reversed-phase, size exclusion, ion exchange, hydrophilic and hydrophobic interaction chromatography.
Register Free: https://www.chromatographyonline.com/ca_w/unlock